HEADER IMMUNE SYSTEM 24-JUL-14 4QY8 TITLE CRYSTAL STRUCTURE OF ANTI-MSP2 FV FRAGMENT (MAB6D8) IN COMPLEX WITH TITLE 2 3D7-MSP2 14-30 COMPND MOL_ID: 1; COMPND 2 MOLECULE: FV FRAGMENT(MAB6D8) HEAVY CHAIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: FV FRAGMENT(MAB6D8) LIGHT CHAIN; COMPND 7 CHAIN: B; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: MEROZOITE SURFACE ANTIGEN 2; COMPND 11 CHAIN: Q; COMPND 12 FRAGMENT: UNP RESIDUES 33-49; COMPND 13 SYNONYM: MEROZOITE SURFACE PROTEIN 2, MSA-2, 45 KDA MEROZOITE SURFACE COMPND 14 ANTIGEN; COMPND 15 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_TAXID: 10090; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 8 ORGANISM_TAXID: 10090; SOURCE 9 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 10 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 11 MOL_ID: 3; SOURCE 12 SYNTHETIC: YES; SOURCE 13 ORGANISM_SCIENTIFIC: PLASMODIUM FALCIPARUM 3D7; SOURCE 14 ORGANISM_TAXID: 36329 KEYWDS IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM, N-TERMINAL MSP2, UNSTRUCTURED KEYWDS 2 ANTIGEN EXPDTA X-RAY DIFFRACTION AUTHOR R.A.V.MORALES,C.A.MACRAILD,J.SEOW,K.BANKALA,N.DRINKWATER,S.MCGOWAN, AUTHOR 2 R.ROUET,D.CHRIST,R.F.ANDERS,R.S.NORTON REVDAT 2 08-NOV-23 4QY8 1 REMARK SEQADV LINK REVDAT 1 03-JUN-15 4QY8 0 JRNL AUTH R.A.MORALES,C.A.MACRAILD,J.SEOW,B.KRISHNARJUNA,N.DRINKWATER, JRNL AUTH 2 R.ROUET,R.F.ANDERS,D.CHRIST,S.MCGOWAN,R.S.NORTON JRNL TITL STRUCTURAL BASIS FOR EPITOPE MASKING AND STRAIN SPECIFICITY JRNL TITL 2 OF A CONSERVED EPITOPE IN AN INTRINSICALLY DISORDERED JRNL TITL 3 MALARIA VACCINE CANDIDATE. JRNL REF SCI REP V. 5 10103 2015 JRNL REFN ESSN 2045-2322 JRNL PMID 25965408 JRNL DOI 10.1038/SREP10103 REMARK 2 REMARK 2 RESOLUTION. 1.35 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.8.4_1496) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.35 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.23 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.3 REMARK 3 NUMBER OF REFLECTIONS : 44199 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.153 REMARK 3 R VALUE (WORKING SET) : 0.152 REMARK 3 FREE R VALUE : 0.165 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.080 REMARK 3 FREE R VALUE TEST SET COUNT : 2247 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 34.2406 - 3.4072 0.99 2711 161 0.1312 0.1337 REMARK 3 2 3.4072 - 2.7048 0.99 2696 141 0.1328 0.1440 REMARK 3 3 2.7048 - 2.3630 0.99 2650 161 0.1393 0.1744 REMARK 3 4 2.3630 - 2.1470 0.99 2635 165 0.1318 0.1394 REMARK 3 5 2.1470 - 1.9931 0.98 2619 155 0.1374 0.1435 REMARK 3 6 1.9931 - 1.8756 0.98 2650 133 0.1373 0.1665 REMARK 3 7 1.8756 - 1.7817 0.98 2625 157 0.1548 0.1583 REMARK 3 8 1.7817 - 1.7041 0.97 2592 145 0.1564 0.1855 REMARK 3 9 1.7041 - 1.6385 0.97 2616 135 0.1690 0.1794 REMARK 3 10 1.6385 - 1.5820 0.97 2629 136 0.1745 0.2330 REMARK 3 11 1.5820 - 1.5325 0.97 2608 137 0.1914 0.1848 REMARK 3 12 1.5325 - 1.4887 0.97 2599 120 0.1963 0.2290 REMARK 3 13 1.4887 - 1.4495 0.97 2602 119 0.2105 0.2467 REMARK 3 14 1.4495 - 1.4141 0.96 2599 127 0.2331 0.3016 REMARK 3 15 1.4141 - 1.3820 0.96 2604 122 0.2460 0.2719 REMARK 3 16 1.3820 - 1.3526 0.94 2517 133 0.2522 0.2569 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.120 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 17.960 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 1875 REMARK 3 ANGLE : 1.100 2547 REMARK 3 CHIRALITY : 0.069 279 REMARK 3 PLANARITY : 0.004 332 REMARK 3 DIHEDRAL : 11.746 673 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 19.5541 16.9193 32.9832 REMARK 3 T TENSOR REMARK 3 T11: 0.0701 T22: 0.0781 REMARK 3 T33: 0.0664 T12: 0.0128 REMARK 3 T13: 0.0051 T23: 0.0180 REMARK 3 L TENSOR REMARK 3 L11: 0.7822 L22: 1.1552 REMARK 3 L33: 0.6905 L12: 0.2759 REMARK 3 L13: 0.3319 L23: 0.4921 REMARK 3 S TENSOR REMARK 3 S11: -0.0500 S12: 0.0530 S13: 0.0286 REMARK 3 S21: -0.0482 S22: 0.0451 S23: 0.0517 REMARK 3 S31: -0.0088 S32: 0.0552 S33: 0.0025 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4QY8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 07-AUG-14. REMARK 100 THE DEPOSITION ID IS D_1000086663. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-APR-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.2 REMARK 200 NUMBER OF CRYSTALS USED : 2 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9537 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 44204 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.350 REMARK 200 RESOLUTION RANGE LOW (A) : 34.390 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.4 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.35 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.43 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.59000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4QYO REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.45 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEG 8000, 0.2M NACL, 0.1M NAOAC, REMARK 280 PH 4.2, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 30.16150 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3110 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10430 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -17.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, Q REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS Q 28 REMARK 465 PRO Q 29 REMARK 465 SER Q 30 REMARK 465 NH2 Q 31 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 3 CG CD OE1 NE2 REMARK 470 LYS A 30 CD CE NZ REMARK 470 GLU A 42 CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 247 O HOH B 360 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OG SER B 7 O HOH Q 106 2757 2.18 REMARK 500 O HOH A 358 O HOH B 305 1454 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 99 68.90 63.48 REMARK 500 ALA B 55 -42.74 76.44 REMARK 500 ALA B 88 173.95 179.42 REMARK 500 MET Q 24 59.14 -158.28 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACE Q 13 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN Q OF MEROZOITE SURFACE REMARK 800 ANTIGEN 2 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4QXT RELATED DB: PDB REMARK 900 THE SAME FV FRAGMENT COMPLEXED WITH FC27-MSP2 14-30 REMARK 900 RELATED ID: 4QYO RELATED DB: PDB REMARK 900 ANTI-MSP2 FV FRAGMENT (MAB6D8)IN COMPLEX WITH MSP2 14-22 DBREF 4QY8 A 1 114 PDB 4QY8 4QY8 1 114 DBREF 4QY8 B 1 111 PDB 4QY8 4QY8 1 111 DBREF 4QY8 Q 14 30 UNP P50498 MSA2_PLAF7 33 49 SEQADV 4QY8 ACE Q 13 UNP P50498 ACETYLATION SEQADV 4QY8 NH2 Q 31 UNP P50498 AMIDATION SEQRES 1 A 114 GLN VAL GLN LEU GLN GLN SER GLY ASP GLU LEU VAL LYS SEQRES 2 A 114 PRO GLY ALA SER VAL LYS LEU SER CYS THR VAL SER GLY SEQRES 3 A 114 PHE ASN ILE LYS ASP ASP PHE ILE HIS TRP MET LYS GLN SEQRES 4 A 114 ARG PRO GLU GLN GLY LEU GLU TRP ILE GLY ARG ILE ASP SEQRES 5 A 114 PRO ALA ASN GLY TYR THR LYS TYR ALA PRO LYS PHE GLN SEQRES 6 A 114 ASP LYS ALA THR MET THR ALA ASP THR SER SER ASN THR SEQRES 7 A 114 ALA TYR LEU GLN LEU SER SER LEU ALA SER GLU ASP ALA SEQRES 8 A 114 ALA VAL TYR TYR CYS ALA THR TYR GLY VAL ALA TYR TRP SEQRES 9 A 114 GLY GLN GLY THR LEU VAL THR VAL SER ALA SEQRES 1 B 111 ASP ILE VAL LEU THR GLN SER PRO ALA SER LEU ALA VAL SEQRES 2 B 111 SER LEU GLY GLN ARG ALA THR ILE SER CYS LYS ALA SER SEQRES 3 B 111 GLN SER VAL ASP HIS ASP GLY ASP SER TYR MET ASN TRP SEQRES 4 B 111 PHE GLN GLN LYS PRO GLY GLN SER PRO LYS LEU LEU ILE SEQRES 5 B 111 TYR ALA ALA SER ASN LEU GLU SER GLY ILE PRO ALA ARG SEQRES 6 B 111 PHE SER GLY SER GLY SER GLY THR ASP PHE THR LEU ASN SEQRES 7 B 111 ILE HIS PRO VAL GLU GLU GLU ASP ALA ALA THR TYR TYR SEQRES 8 B 111 CYS GLN GLN THR ASN GLU ASP PRO TYR THR PHE GLY GLY SEQRES 9 B 111 GLY THR LYS LEU GLU ILE LYS SEQRES 1 Q 19 ACE ASN ALA TYR ASN MET SER ILE ARG ARG SER MET ALA SEQRES 2 Q 19 GLU SER LYS PRO SER NH2 HET ACE Q 13 3 HETNAM ACE ACETYL GROUP FORMUL 3 ACE C2 H4 O FORMUL 4 HOH *369(H2 O) HELIX 1 1 ASN A 28 ASP A 32 5 5 HELIX 2 2 PRO A 62 GLN A 65 5 4 HELIX 3 3 ALA A 87 ALA A 91 5 5 HELIX 4 4 GLU B 83 ALA B 87 5 5 SHEET 1 A 4 GLN A 3 GLN A 6 0 SHEET 2 A 4 VAL A 18 SER A 25 -1 O THR A 23 N GLN A 5 SHEET 3 A 4 THR A 78 LEU A 83 -1 O LEU A 83 N VAL A 18 SHEET 4 A 4 ALA A 68 ASP A 73 -1 N THR A 71 O TYR A 80 SHEET 1 B 6 GLU A 10 VAL A 12 0 SHEET 2 B 6 THR A 108 VAL A 112 1 O THR A 111 N VAL A 12 SHEET 3 B 6 ALA A 92 THR A 98 -1 N ALA A 92 O VAL A 110 SHEET 4 B 6 ILE A 34 ARG A 40 -1 N HIS A 35 O ALA A 97 SHEET 5 B 6 GLY A 44 ILE A 51 -1 O GLU A 46 N LYS A 38 SHEET 6 B 6 THR A 58 TYR A 60 -1 O LYS A 59 N ARG A 50 SHEET 1 C 4 GLU A 10 VAL A 12 0 SHEET 2 C 4 THR A 108 VAL A 112 1 O THR A 111 N VAL A 12 SHEET 3 C 4 ALA A 92 THR A 98 -1 N ALA A 92 O VAL A 110 SHEET 4 C 4 TYR A 103 TRP A 104 -1 O TYR A 103 N THR A 98 SHEET 1 D 4 LEU B 4 SER B 7 0 SHEET 2 D 4 ALA B 19 ALA B 25 -1 O SER B 22 N SER B 7 SHEET 3 D 4 ASP B 74 ILE B 79 -1 O PHE B 75 N CYS B 23 SHEET 4 D 4 PHE B 66 SER B 71 -1 N SER B 67 O ASN B 78 SHEET 1 E 6 SER B 10 VAL B 13 0 SHEET 2 E 6 THR B 106 ILE B 110 1 O GLU B 109 N LEU B 11 SHEET 3 E 6 ALA B 88 GLN B 94 -1 N ALA B 88 O LEU B 108 SHEET 4 E 6 MET B 37 GLN B 42 -1 N ASN B 38 O GLN B 93 SHEET 5 E 6 LYS B 49 TYR B 53 -1 O LEU B 51 N TRP B 39 SHEET 6 E 6 ASN B 57 LEU B 58 -1 O ASN B 57 N TYR B 53 SHEET 1 F 4 SER B 10 VAL B 13 0 SHEET 2 F 4 THR B 106 ILE B 110 1 O GLU B 109 N LEU B 11 SHEET 3 F 4 ALA B 88 GLN B 94 -1 N ALA B 88 O LEU B 108 SHEET 4 F 4 THR B 101 PHE B 102 -1 O THR B 101 N GLN B 94 SHEET 1 G 2 ASP B 30 HIS B 31 0 SHEET 2 G 2 ASP B 34 SER B 35 -1 O ASP B 34 N HIS B 31 SSBOND 1 CYS A 22 CYS A 96 1555 1555 2.05 SSBOND 2 CYS B 23 CYS B 92 1555 1555 2.06 LINK C ACE Q 13 N ASN Q 14 1555 1555 1.34 CISPEP 1 SER B 7 PRO B 8 0 -2.17 CISPEP 2 SER B 7 PRO B 8 0 -2.15 CISPEP 3 HIS B 80 PRO B 81 0 -8.45 CISPEP 4 ASP B 98 PRO B 99 0 -1.98 SITE 1 AC1 7 TYR B 53 LEU B 58 GLU B 59 SER B 60 SITE 2 AC1 7 HOH B 238 ASN Q 14 ALA Q 15 SITE 1 AC2 35 ASP A 31 ASP A 32 PHE A 33 ARG A 50 SITE 2 AC2 35 ASP A 52 ASN A 55 TYR A 57 TYR A 99 SITE 3 AC2 35 GLY A 100 VAL A 101 HIS B 31 ASP B 34 SITE 4 AC2 35 TYR B 36 ASN B 38 TYR B 53 GLU B 59 SITE 5 AC2 35 THR B 95 ASN B 96 TYR B 100 HOH B 201 SITE 6 AC2 35 HOH B 228 HOH B 375 ACE Q 13 HOH Q 101 SITE 7 AC2 35 HOH Q 102 HOH Q 106 HOH Q 107 HOH Q 108 SITE 8 AC2 35 HOH Q 109 HOH Q 110 HOH Q 111 HOH Q 112 SITE 9 AC2 35 HOH Q 117 HOH Q 118 HOH Q 120 CRYST1 42.107 60.323 43.477 90.00 107.03 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023749 0.000000 0.007274 0.00000 SCALE2 0.000000 0.016577 0.000000 0.00000 SCALE3 0.000000 0.000000 0.024055 0.00000